Condition: Thyroid Eye Disease (TED) · Sponsor: Zai Lab (Shanghai) Co., Ltd.
A Multicenter, Double-blinded, Randomized, Placebo-controlled Phase 3 Study of ZL-1109 in Chinese Participants with Thyroid Eye Disease (TED)
This description comes directly from the study's public registry record.
ZL-1109-002 Study Team · 86 021-61632588 · 1109-002_studyteam@zailaboratory.com
Always discuss trial participation with your own doctor first.
| Site01006 | Beijing, China | Not Yet Recruiting |
| Site01009 | Beijing, China | Recruiting |
| Site01010 | Beijing, China | Not Yet Recruiting |
| Site01029 | Bengbu, China | Not Yet Recruiting |
| Site01020 | Changsha, China | Not Yet Recruiting |
| Site01022 | Chengdu, China | Not Yet Recruiting |
| Site01031 | Chongqing, China | Recruiting |
| Site01011 | Dalian, China | Not Yet Recruiting |
| Site01008 | Foshan, China | Recruiting |
| Site01004 | Fuzhou, China | Recruiting |
| Site01007 | Guangzhou, China | Recruiting |
| Site01027 | Guiyang, China | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07211776